" Funding from the Sontag Foundation is allowing my lab to pursue innovative, breakthrough technologies and discover fundamental biological insights that may ultimately be translated to more effective treatments for aggressive cancer types, especially primary brain tumors such as GBM."
About DSA-Funded Research
Dr. Chen is leading a research group to seek global understandings of the molecular and cellular factors controlling disease progression and immunity. His group continuously invents versatile systems that enable rapid identification of novel targets and development of new modalities of cancer immunotherapy, cell therapy and gene therapy. His goal is to uncover novel insights in cancer and various other immunological diseases and develop next generation therapeutics.
Associate Professor of Genetics, Yale School of Medicine
Peking University, B.S. Biological Science
The University of Chicago, M.S. Evolutionary Genetics, Computational Biology
Stanford University, Visiting student, Biology
The University of Chicago, Ph.D., Evolutionary Genetics
Broad Institute, Visiting Postdoctoral Fellow, Genome Engineering